Medicine & Health
Updates every hour. Last Updated: 14-Aug-2025 22:11 ET (15-Aug-2025 02:11 GMT/UTC)
20-Mar-2025
Xylazine detected in U.S.-Mexico border drug supply, study finds
University of California - San DiegoPeer-Reviewed Publication
Researchers at UC San Diego have confirmed the presence of xylazine in the illicit drug supply at the U.S.-Mexico border. While xylazine remains less common in the Western U.S., border cities serve as key trafficking hubs and may have higher rates of emerging substances.
- Journal
- Journal of Addiction Medicine
20-Mar-2025
Prevalence and severity of astigmatism in children after COVID-19
JAMA NetworkPeer-Reviewed Publication
About The Study: In this study, lifestyle changes after the pandemic were associated with an increase in the prevalence and severity of child astigmatisms, likely associated with changes in the developing cornea. The potential impact of higher degrees of astigmatism may warrant dedicated efforts to elucidate the relationship between environmental and/or lifestyle factors, as well as the pathophysiology of astigmatism.
- Journal
- JAMA Ophthalmology
20-Mar-2025
Cancer antigen 125 levels at time of ovarian cancer diagnosis by race and ethnicity
JAMA NetworkPeer-Reviewed Publication
About The Study: In this cohort study of patients with ovarian cancer, American Indian and Black patients were 23% less likely to have an elevated cancer antigen (CA)-125 level at diagnosis. Current CA-125 thresholds may miss racially and ethnically diverse patients with ovarian cancer. International guidelines use CA-125 thresholds to recommend which patients with pelvic masses should undergo evaluation by gynecologic oncologists for ovarian cancer. However, CA-125 thresholds were developed from white populations. Work is needed to develop inclusive CA-125 thresholds and diagnostic guidelines and not compound disparities in ovarian cancer diagnosis and treatment.
- Journal
- JAMA Network Open
20-Mar-2025
Evaluation of inhaled technosphere insulin plus insulin degludec for adults with type 1 diabetes
Mary Ann Liebert, Inc./Genetic Engineering News
A new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) concluded that inhaled technosphere insulin (TI-Afrezza) should be considered as an option for individuals with type 1 diabetes who want an alternative to using an insulin pump or multiple daily injections (MDI) for insulin delivery.
- Journal
- Diabetes Technology & Therapeutics
20-Mar-2025
Improving patient experience for the millions who visit an ED annually
Regenstrief InstitutePeer-Reviewed Publication
A large scale study by researchers from the Regenstrief Institute and the Indiana University School of Medicine has found that patient pain upon arrival to the Emergency Department (ED) as well as the use of hallway beds and radiology studies in the ED are associated with patient experience, although not in the same ways.
- Journal
- Annals of Emergency Medicine
- Funder
- Ralph W. and Grace M. Showalter Research Trust Fund, Indiana University School of Medicine
20-Mar-2025
Potential treatment for chronic kidney disease in dogs revealed
The Hebrew University of JerusalemPeer-Reviewed Publication
A new study led by Dr. Hilla Chen, Prof. Gilad Segev and Dr. Michal Mazaki-Tovi from the Koret School of Veterinary Medicine at Hebrew University, recently published in Journal of Veterinary Internal Medicine, offers new hope for the management of chronic kidney disease (CKD) in dogs. The research highlights the potential benefits of paricalcitol, a second-generation vitamin D analog, in addressing renal secondary hyperparathyroidism (RHPT) and proteinuria—two critical complications of CKD.
- Journal
- Journal of Veterinary Internal Medicine